Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein

被引:58
作者
Irungu, Janet [1 ]
Go, Eden P. [1 ]
Zhang, Ying [1 ]
Dalpathado, Dilushat S. [1 ]
Liao, Hua-Xin [2 ]
Haynes, Barton F. [2 ]
Desaire, Heather [1 ]
机构
[1] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
关键词
D O I
10.1016/j.jasms.2008.05.010
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Defining the structures and locations of the glycans attached on secreted proteins and virus envelope proteins is important in understanding how glycosylation affects their biological properties. Glycopeptide mass spectrometry (MS)-based analysis is a very powerful, emerging approach to characterize glycoproteins, in which glycosylation sites and the corresponding glycan structures are elucidated in a single MS experiment. However, to date there is not a consensus regarding which mass spectrometric platform provides the best glycosylation coverage information. Herein, we employ two of the most widely used MS approaches, online high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC/ESI-MS) and offline HPLC followed by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS), to determine which of the two approaches provides the best glycosylation coverage information of a complex glycoprotein, the group M consensus HIV-1 envelope, CON-S gp140 Delta CFI, which has 31 potential glycosylation sites. Our results highlight differences in the informational content obtained between the two methods such as the overall number of glycosylation sites detected, the numbers of N-linked glycans present at each site, and the type of confirmatory information obtained about the glycopeptide using MS/MS experiments. The two approaches are quite complementary, both in their coverage of glycopeptides and in the information they provide in MS/MS experiments. The information in this study contributes to the field of mass spectrometry by demonstrating the strengths and limitations of two widely used MS platforms in glycoprotein analysis.
引用
收藏
页码:1209 / 1220
页数:12
相关论文
共 38 条
[1]   On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database [J].
Apweiler, R ;
Hermjakob, H ;
Sharon, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :4-8
[2]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[3]  
BAENZIGER JU, 1985, AM J PATHOL, V121, P382
[4]  
Brancia FL, 2000, RAPID COMMUN MASS SP, V14, P2070, DOI 10.1002/1097-0231(20001115)14:21<2070::AID-RCM133>3.0.CO
[5]  
2-G
[6]   Global methods for protein glycosylation analysis by mass spectrometry [J].
Budnik, Bogdan A. ;
Lee, Richard S. ;
Steen, Judith A. J. .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2006, 1764 (12) :1870-1880
[7]   Characterization of protein glycosylation by mass spectrometry [J].
Burlingame, AL .
CURRENT OPINION IN BIOTECHNOLOGY, 1996, 7 (01) :4-10
[8]   CARBOHYDRATE MAPPING BY MASS-SPECTROMETRY - A NOVEL METHOD FOR IDENTIFYING ATTACHMENT SITES OF ASN-LINKED SUGARS IN GLYCOPROTEINS [J].
CARR, SA ;
ROBERTS, GD .
ANALYTICAL BIOCHEMISTRY, 1986, 157 (02) :396-406
[9]  
Carrera A, 1993, Strabismus, V1, P3, DOI 10.3109/09273979309033847
[10]   Selection for neutralization resistance of the simian human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation [J].
Cheng-Mayer, C ;
Brown, A ;
Harouse, J ;
Luciw, PA ;
Mayer, AJ .
JOURNAL OF VIROLOGY, 1999, 73 (07) :5294-5300